Home
NSE: VANTABIOSCIENCE
ISIN
NSE: VANTABIOSCIENCE
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
04 Feb 2025 | 39.45 |
03 Feb 2025 | 38.45 |
01 Feb 2025 | 37.45 |
31 Jan 2025 | 35.69 |
28 Jan 2025 | 34 |
27 Jan 2025 | 34.31 |
24 Jan 2025 | 36.11 |
23 Jan 2025 | 38.01 |
22 Jan 2025 | 38 |
21 Jan 2025 | 38 |
Company Name | ISIN Code |
---|---|
Hindustan Unilever Ltd | INE030A01027 |
Nestle India Ltd | INE239A01024 |
Britannia Industries Ltd | INE216A01030 |
Godrej Consumer Products Ltd | INE102D01028 |
Varun Beverages Ltd | INE200M01039 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Vanta Bioscience Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Vanta Bioscience Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 6 December 2024 Pow
Read more
04 Dec 24
Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po
Read more
12 Nov 24
Vanta Bioscience announced that an Extra Ordinary General Meeting (EGM) of the Company will be held
Read more
10 Dec 24